XENON PHARMACEUTICALS INC shareholders Q3 2023

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.

XENON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Elmwood Wealth Management, Inc. 10,069$343,9580.17%
Soleus Capital Management, L.P. 52,000$1,776,3200.16%
MARSHALL WACE, LLP 2,154,394$73,594,1000.15%
Baker Brothers Advisors 751,639$25,675,9880.15%
SANDERS MORRIS HARRIS LLC 21,500$718,1000.15%
LORD, ABBETT & CO. LLC 1,149,168$39,2560.15%
Supplemental Annuity Collective Trust of NJ 11,000$375,7600.14%
Candriam S.C.A. 569,884$19,467,2370.14%
NJ State Employees Deferred Compensation Plan 25,000$854,0000.13%
PFM Health Sciences, LP 78,587$2,684,5320.13%
ExodusPoint Capital Management, LP 359,838$12,2920.12%
Point72 Asset Management, L.P. 1,125,708$38,454,1850.11%
Caption Management, LLC 187,000$6,387,9200.10%
Moran Wealth Management, LLC 69,510$2,374,4620.09%
Pictet Asset Management Holding SA 1,938,779$66,228,6910.08%
Fiera Capital Corp 560,546$19,148,2520.06%
MOODY ALDRICH PARTNERS LLC 9,123$311,6420.06%
Legato Capital Management LLC 11,682$399,0570.06%
Woodline Partners LP 143,451$4,900,2860.06%
Schonfeld Strategic Advisors LLC 198,984$6,797,2930.05%
External links

This page lists XENON PHARMACEUTICALS INC's shareholders in Q3 2023. To view XENON PHARMACEUTICALS INC's shareholder history, click here.